James Treco - 20 Aug 2025 Form 4 Insider Report for Tonix Pharmaceuticals Holding Corp. (TNXP)

Role
Director
Signature
/s/ Jessica Morris, Attorney-in-Fact
Issuer symbol
TNXP
Transactions as of
20 Aug 2025
Net transactions value
+$9,000
Form type
4
Filing time
20 Aug 2025, 16:15:15 UTC
Previous filing
15 May 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Treco James Director C/O TONIX PHARMACEUTICALS HOLDING CORP, 26 MAIN STREET, SUITE 101, CHATHAM /s/ Jessica Morris, Attorney-in-Fact 20 Aug 2025 0001766070

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction TNXP Common Stock, par value $0.001 Purchase $9,000 +250 $36.00 250 20 Aug 2025 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.